| 1 | 21946411 | MiR-129-5p is required for histone deacetylase inhibitor-induced cell death in thyroid cancer cells. | Endocr Relat Cancer | 2011 Dec |
3 |
| 2 | 25270294 | Rapamycin reveals an mTOR-independent repression of Kv1.1 expression during epileptogenesis. | Neurobiol Dis | 2015 Jan |
1 |
| 3 | 25344911 | Methylation of miR-129-5p CpG island modulates multi-drug resistance in gastric cancer by targeting ABC transporters. | Oncotarget | 2014 Nov 30 |
2 |
| 4 | 25566966 | Demethylation-mediated miR-129-5p up-regulation inhibits malignant phenotype of osteogenic osteosarcoma by targeting Homo sapiens valosin-containing protein (VCP). | Tumour Biol | 2015 May |
2 |
| 5 | 26638170 | Norcantharidin induces autophagy-related prostate cancer cell death through Beclin-1 upregulation by miR-129-5p suppression. | Tumour Biol | 2015 Dec 5 |
1 |
| 6 | 27001970 | microRNA-129-5p, a c-Myc negative target, affects hepatocellular carcinoma progression by blocking the Warburg effect. | J Mol Cell Biol | 2016 Oct 1 |
2 |
| 7 | 27029378 | Synergistic Therapy of Doxorubicin and miR-129-5p with Self-Cross-Linked Bioreducible Polypeptide Nanoparticles Reverses Multidrug Resistance in Cancer Cells. | Biomacromolecules | 2016 May 9 |
4 |
| 8 | 27831649 | MiR-129-5p is downregulated in breast cancer cells partly due to promoter H3K27m3 modification and regulates epithelial-mesenchymal transition and multi-drug resistance. | Eur Rev Med Pharmacol Sci | 2016 Oct |
2 |
| 9 | 28487411 | A microRNA-129-5p/Rbfox crosstalk coordinates homeostatic downscaling of excitatory synapses. | EMBO J | 2017 Jun 14 |
4 |
| 10 | 28619508 | MiR-129-5p inhibits non-small cell lung cancer cell stemness and chemoresistance through targeting DLK1. | Biochem Biophys Res Commun | 2017 Aug 19 |
3 |
| 11 | 28667779 | Suberoylanilide hydroxamic acid induces thioredoxin1-mediated apoptosis in lung cancer cells via up-regulation of miR-129-5p. | Mol Carcinog | 2017 Dec |
2 |
| 12 | 29377229 | microRNA-129-5p involved in the neuroprotective effect of dexmedetomidine on hypoxic-ischemic brain injury by targeting COL3A1 through the Wnt/β-catenin signaling pathway in neonatal rats. | J Cell Biochem | 2018 Jan 27 |
3 |
| 13 | 29531296 | miR-129-5p targets Wnt5a to block PKC/ERK/NF-κB and JNK pathways in glioblastoma. | Cell Death Dis | 2018 Mar 12 |
1 |
| 14 | 29802821 | microRNA-129-5p suppresses Adriamycin resistance in breast cancer by targeting SOX2. | Arch Biochem Biophys | 2018 Aug 1 |
8 |
| 15 | 30117016 | miR-129-5p inhibits gemcitabine resistance and promotes cell apoptosis of bladder cancer cells by targeting Wnt5a. | Int Urol Nephrol | 2018 Oct |
6 |
| 16 | 30372807 | Through oxaliplatin resistance induction in colorectal cancer cells, increasing ABCB1 level accompanies decreasing level of miR-302c-5p, miR-3664-5p and miR-129-5p. | Biomed Pharmacother | 2018 Dec |
1 |
| 17 | 30460078 | MicroRNA-129-5p inhibits 3T3-L1 preadipocyte proliferation by targeting G3BP1. | Anim Cells Syst (Seoul) | 2017 |
2 |
| 18 | 30521373 | MicroRNA-129-5p is regulated by choline availability and controls EGF receptor synthesis and neurogenesis in the cerebral cortex. | FASEB J | 2019 Mar |
2 |
| 19 | 30604866 | Timosaponin AIII inhibits metastasis of renal carcinoma cells through suppressing cathepsin C expression by AKT/miR-129-5p axis. | J Cell Physiol | 2019 Aug |
2 |
| 20 | 31444414 | Long non-coding RNA NONHSAT101069 promotes epirubicin resistance, migration, and invasion of breast cancer cells through NONHSAT101069/miR-129-5p/Twist1 axis. | Oncogene | 2019 Nov |
2 |
| 21 | 31661546 | MiR-129-5p regulates cell proliferation and apoptosis via IGF-1R/Src/ERK/Egr-1 pathway in RA-fibroblast-like synoviocytes. | Biosci Rep | 2019 Dec 20 |
1 |
| 22 | 31664305 | Upregulation of miR-129-5p increases the sensitivity to Taxol through inhibiting HMGB1-mediated cell autophagy in breast cancer MCF-7 cells. | Braz J Med Biol Res | 2019 |
5 |
| 23 | 31772586 | miR-129-5p Regulates the Immunomodulatory Functions of Adipose-Derived Stem Cells via Targeting Stat1 Signaling. | Stem Cells Int | 2019 |
3 |
| 24 | 31814565 | [Downregulation of miR-129-5p alleviates alcohol-induced barrier dysfunction of Caco-2 human intestinal epithelial cells]. | Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi | 2019 Oct |
5 |
| 25 | 31815867 | Long Noncoding RNA NEAT1 Promotes Myocardiocyte Apoptosis and Suppresses Proliferation Through Regulation of miR-129-5p. | J Cardiovasc Pharmacol | 2019 Dec |
1 |
| 26 | 31876385 | MiR-129-5p promotes docetaxel resistance in prostate cancer by down-regulating CAMK2N1 expression. | J Cell Mol Med | 2020 Feb |
7 |
| 27 | 31949489 | MiR-129-5p sensitization of lung cancer cells to etoposide-induced apoptosis by reducing YWHAB. | J Cancer | 2020 |
3 |
| 28 | 32039732 | DNA-methylation-mediated activating of lncRNA SNHG12 promotes temozolomide resistance in glioblastoma. | Mol Cancer | 2020 Feb 10 |
1 |
| 29 | 32210737 | Inhibition of ZEB1-AS1 confers cisplatin sensitivity in breast cancer by promoting microRNA-129-5p-dependent ZEB1 downregulation. | Cancer Cell Int | 2020 |
1 |
| 30 | 32255569 | MiR-129-5p alleviates myocardial injury by targeting suppressor of cytokine signaling 2 after ischemia/reperfusion. | Kaohsiung J Med Sci | 2020 Aug |
4 |
| 31 | 32335272 | miR-129-5p: A key factor and therapeutic target in amyotrophic lateral sclerosis. | Prog Neurobiol | 2020 Jul |
2 |
| 32 | 32552008 | <i>MiR-129-5p</i> Restrains Apatinib Resistance in Human Gastric Cancer Cells Via Downregulating <i>HOXC10</i>. | Cancer Biother Radiopharm | 2021 Feb |
5 |
| 33 | 33122949 | Circ_0000260 Regulates the Development and Deterioration of Gastric Adenocarcinoma with Cisplatin Resistance by Upregulating MMP11 via Targeting MiR-129-5p. | Cancer Manag Res | 2020 |
3 |
| 34 | 33131409 | Depletion of circ_0007841 inhibits multiple myeloma development and BTZ resistance via miR-129-5p/JAG1 axis. | Cell Cycle | 2020 Dec |
1 |
| 35 | 33228663 | LncRNA NEAT1/microRNA-129-5p/SOCS2 axis regulates liver fibrosis in alcoholic steatohepatitis. | J Transl Med | 2020 Nov 24 |
3 |
| 36 | 33433643 | Mechanism of Cyclic Tensile Stress in Osteogenic Differentiation of Human Periodontal Ligament Stem Cells. | Calcif Tissue Int | 2021 May |
1 |
| 37 | 33505161 | Propofol Inhibits the Progression of Cervical Cancer by Regulating HOTAIR/miR-129-5p/RPL14 Axis. | Onco Targets Ther | 2021 |
3 |
| 38 | 33535837 | <i>In vitro</i> and <i>in vivo</i> assessment of the protective effect of sufentanil in acute lung injury. | J Int Med Res | 2021 Feb |
2 |
| 39 | 33569456 | The protective effects of the miR-129-5p/keap-1/Nrf2 axis on Ang II-induced cardiomyocyte hypertrophy. | Ann Transl Med | 2021 Jan |
1 |
| 40 | 33732018 | MiR-129-5p Suppresses Cell Proliferation of Human Osteosarcoma Cancer by Down-Regulating LncRNA Lnc712. | Cancer Manag Res | 2021 |
1 |
| 41 | 34003528 | Withdrawn: 'Circular RNA PTGR1 regulates 5-FU resistance and development of hepatocellular carcinoma cells by modulating miR-129-5p/ABCC1 axis' by, Xiuxiu Li, and Ti Zhang. | Cell Biol Int | 2021 Nov |
3 |
| 42 | 34132932 | Long non-coding RNA OIP5-AS1 inhibition upregulates microRNA-129-5p to repress resistance to temozolomide in glioblastoma cells via downregulating IGF2BP2. | Cell Biol Toxicol | 2021 Jun 16 |
4 |
| 43 | 34286514 | LncRNA PCGEM1 mediates oxaliplatin resistance in hepatocellular carcinoma via miR-129-5p/ETV1 axis in vitro. | Adv Clin Exp Med | 2021 Aug |
2 |
| 44 | 34512893 | Clinical significance of serum miR-129-5p in patients with diabetes mellitus presenting macrovascular complications. | World J Diabetes | 2021 Aug 15 |
7 |
| 45 | 34528223 | Clinical Value and Role of miR-129-5p in Non-Alcoholic Fatty Liver Disease. | Horm Metab Res | 2021 Oct |
4 |
| 46 | 34777000 | Human Bone Marrow Mesenchymal Stromal Cell-Derived Extracellular Vesicles Promote Proliferation of Degenerated Nucleus Pulposus Cells and the Synthesis of Extracellular Matrix Through the SOX4/Wnt/β-Catenin Axis. | Front Physiol | 2021 |
1 |
| 47 | 34778251 | A miR-129-5P/ARID3A Negative Feedback Loop Modulates Diffuse Large B Cell Lymphoma Progression and Immune Evasion Through Regulating the PD-1/PD-L1 Checkpoint. | Front Cell Dev Biol | 2021 |
2 |
| 48 | 34925523 | Breviscapine Participates in the Progression of Prostate Cancer by Inhibiting ZFP91 Expression through Upregulation of MicroRNA-129-5p. | Evid Based Complement Alternat Med | 2021 |
7 |